Bitte melden Sie sich an, um fortzufahren!
PressReleaseFinder bietet Ihnen aktuelle Neuigkeiten und Links zu Firmenwebseiten auch ohne Registrierung. Für Zugriff auf das gesamte Pressematerial, einschließlich hoch auflösender Bilder, bitten wir Sie jedoch, sich kostenlos registrieren zu lassen. Sie erhalten dann einen Link per eMail, mit dem Sie sich sofort einwählen können. Passwort vergessen? Klicken Sie hier!
|
 |
|
|
DSM Biomedical
To meet the upcoming needs of the medical and biotech industries, DSM Biomedical builds on the expertise and strengths of DSM in polymers, coating technology, materials science and life sciences. DSM’s current biomedical portfolio includes ComfortCoat™ hydrophilic and antimicrobial coating technology for catheters, guidewires and stent delivery systems and Dyneema Purity®, a high performance polyethylene fiber technology, which has been developed specifically for use in medical applications, such as orthopedic implants. Recently the company acquired PTG, a market leader in the field of biomedical polymers Furthermore, a research and development program specifically aimed at extending DSM’s material portfolio for the orthopedic industry has been started. DSM Biomedical is also focusing on developing materials and systems around implantable devices for the musculoskeletal and vascular systems and drug delivery devices in musculoskeletal, vascular and ophthalmic application areas. For more information, visit www.dsmbiomedical.com.
DSM – the Life Sciences and Materials Sciences Company
DSM – the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic prosperity, environmental quality and social equity, which it pursues simultaneously and in parallel. DSM has annual net sales of about € 8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com.
|
|
|
|
DSM Biomedical obtains ISO certification
DSM Biomedical has obtained ISO 13485 certification in recognition of its quality management systems for its medical coating activities. This ISO certification broadens DSM’s access as a qualified supplier in the medical market. ISO certifications for DSM PTG and Dyneema Purity® were already in place.
|
|
|
|
|
|
|
DSM Biomedical receives funding from public-private partnership in biomedical materials
Today DSM Biomedical announced that it will receive funding from the Biomedical Materials Program (BMM), a Dutch public-private partnership in biomedical materials. In total BMM allocated over 50 million Euros to seven R&D projects, four of which were initiated by DSM Biomedical. The funding will help DSM Biomedical to expand its R&D portfolio and accelerate the development time of new biomedical materials, thus contributing to the realization of DSM’s ambition to become a leading player in the biomedical market.
|
|
|
|
|
|
|
DSM expands biomedical portfolio
DSM Biomedical today announced the start of a development program of polyester based Thermoplastic Elastomers (TPE) for use in medical devices. In the coming years DSM Biomedical will work together with medical device companies to develop tailored TPE material grades. These grades will be specifically aimed at making orthopedic devices perform better or, alternatively, at enabling the development of novel products and therapies.
|
|
|
|
|
Mehr über ...
|
|
|
|
|
| Redaktionelle Anfragen |
|
|
|
|
